Stock Update (NYSE:AGN): Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering

[PR Newswire] – DUBLIN and ALISO VIEJO, Calif., Sept. 3, 2015 /PRNewswire/ — Allergan plc (AGN), a leading global pharmaceutical company, and AqueSys, Inc. a private clinical stage medical device company focused on . . . → Read More: Stock Update (NYSE:AGN): Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering Similar Articles: Company Update: Allergan Inc (NYSE:AGN) – Allergan Successfully Completes Oculeve Acquisition Company Update (NYSE:AGN): Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan’s Pending Acquisition of KYTHERA Market Update (NYSE:AGN): Allergan Notes Receipt of Paragraph IV Notification on Restasis